Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Percutaneous left ventricular support devices.

Michael S Lee1, Raj R Makkar

  • 1Cardiovascular Intervention Center, Cedars-Sinai Medical Center, School of Medicine, University of California-Los Angeles, 8631 West Third Street, Los Angeles, CA 90048, USA.

Cardiology Clinics
|June 20, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medicaid Insurance Is Associated With More Complications and Emergency Department Visits but Equivalent 5-Year Secondary Surgery Rate After Primary Hip Arthroscopy.

Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association·2023
Same author

Social Media and Digital Footprints in Orthopaedic Trauma: An Analysis of 1465 Orthopaedic Trauma Association Members.

Journal of orthopaedic trauma·2023
Same author

Dancers Show Significant Improvement in Outcomes and Favorable Return-to-Dance Rates After Primary Hip Arthroscopy With Femoral Head Cartilage Status Being a Predictor of Secondary Surgical Procedures at Mid-Term Follow-Up.

Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association·2023
Same author

A multi-centre case series of patients with coexistent intracranial hypertension and malignant arterial hypertension.

Eye (London, England)·2023
Same author

Clinical Outcomes of Calcium-Channel Blocker vs Beta-Blocker: From the Korean Acute Myocardial Infarction Registry.

JACC. Asia·2023
Same author

Advanced Diabetic Retinopathy May Promote Ocular Neovascularization after Central Retinal Artery Occlusion.

Ophthalmology. Retina·2023
Same journal

At the Edge of the Possible: A New Standard for Cardiovascular Critical Care.

Cardiology clinics·2026
Same journal

End-of-Life Care in the Cardiovascular Intensive Care Unit.

Cardiology clinics·2026
Same journal

Strategies to Reduce Failure to Rescue after Cardiac Surgery.

Cardiology clinics·2026
Same journal

Embracing Enhanced Recovery After Cardiac Surgery Program.

Cardiology clinics·2026
Same journal

Post-Heart Transplantation Intensive Care Unit Recovery: A Phase-Based Approach.

Cardiology clinics·2026
Same journal

A Practical Guide to Intensive Care Unit Management after Left Ventricular Assist Device Implantation.

Cardiology clinics·2026
See all related articles

High-risk percutaneous coronary intervention (PCI) patients may benefit from mechanical circulatory support devices like TandemHeart and Impella. Identifying these patients is crucial for effective hemodynamic support and improved outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Devices

Background:

  • Patients undergoing percutaneous coronary intervention (PCI) with severe left ventricular systolic dysfunction and complex coronary lesions face high risks.
  • These risks include adverse outcomes and hemodynamic collapse, particularly in cases of multivessel, left main, or bypass graft disease.

Purpose of the Study:

  • To evaluate the potential of mechanical circulatory support (MCS) devices in high-risk PCI patients.
  • To identify patient populations most likely to benefit from devices such as TandemHeart and Impella Recover LP 2.5.
  • To underscore the importance of patient selection for MCS therapy.

Main Methods:

  • The abstract discusses the potential application of the TandemHeart percutaneous left ventricular assist device and the Impella Recover LP 2.5 System.

Related Experiment Videos

  • It highlights the need for identifying high-risk patients susceptible to hemodynamic compromise.

    • Main Results:

    • The discussed devices may offer rapid circulatory support for high-risk PCI patients and those in cardiogenic shock.
    • Effective patient identification is key to maximizing the benefits of MCS therapy.

    Conclusions:

    • Mechanical circulatory support devices show promise for specific high-risk PCI patient groups.
    • Further multicenter randomized clinical trials are essential to establish the definitive role of these devices in various clinical scenarios.